Jul 1, 2026 07:30AM
Jul 1, 2026 07:30AM
Jul 1, 2026 07:30AM
Sep 2, 2025 06:56AM
Aug 6, 2025 07:33AM
Jul 11, 2025 07:45AM
Jul 11, 2025 07:43AM Helix Acquisition Corp. II and BridgeBio Oncology Therapeutics Announce Effectiveness of Registration Statement for Proposed Business Combination
Jun 30, 2025 07:30AM
Jun 30, 2025 07:30AM
Mar 15, 2025 04:00PM
Feb 28, 2025 07:50AM
Feb 28, 2025 07:49AM
Feb 15, 2025 10:00PM
Mar 4, 2024 04:46PM After-hours movers: MicroStrategy, GitLab, AeroVironment and more
Jul 17, 2023 10:15AM
Mar 29, 2023 12:46PM
Mar 24, 2023 03:58PM
Nov 3, 2022 07:30AM
Nov 3, 2022 07:30AM
Aug 4, 2022 07:30AM
Aug 4, 2022 07:30AM BridgeBio Pharma, Inc. Reports Second Quarter 2022 Financial Results and Business Update
May 12, 2022 07:31AM
May 12, 2022 07:30AM
May 12, 2022 07:30AM
Mar 8, 2022 07:30AM
Mar 8, 2022 07:30AM
Mar 8, 2022 07:30AM
Feb 24, 2022 07:30AM BridgeBio Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Business Update
Feb 24, 2022 07:30AM
Nov 4, 2021 07:30AM
Aug 18, 2021 07:36AM
Aug 18, 2021 07:30AM
Aug 5, 2021 07:30AM
Jun 29, 2021 04:59AM
Jun 28, 2021 07:10PM BIOMEA Fusion Strengthens its Executive Team with Appointment of Franco Valle as Chief Financial Officer
Jun 28, 2021 07:10PM
May 6, 2021 07:30AM
May 6, 2021 07:30AM
Feb 25, 2021 07:30AM
Feb 25, 2021 07:30AM
Jan 26, 2021 08:30AM
Jan 26, 2021 08:30AM BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc.
Jan 19, 2021 04:01PM
Jan 19, 2021 04:01PM
Jan 13, 2021 04:30PM
Jan 13, 2021 04:30PM
Jan 4, 2021 11:42AM
Jan 4, 2021 07:30AM
Jan 4, 2021 07:30AM Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Proposed Merger
Dec 11, 2020 10:13AM

1,168,807 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All